TY - JOUR
T1 - Physical parameters, use of specific medical treatments, nursing levels, and activities of daily living are potential indicators for forgoing maintenance hemodialysis
AU - Yamaguchi, Nobuko
AU - Yoshida, Tadashi
AU - Oba, Miho
AU - Nakano, Reiko
AU - Saito, Miwa
AU - Hirokawa, Mihoko
AU - Shinmi, Tazuru
AU - Urasawa, Chisa
AU - Oya, Mototsugu
N1 - Publisher Copyright:
© 2019 by The Keio Journal of Medicine.
PY - 2020
Y1 - 2020
N2 - Maintenance hemodialysis (HD) therapy is essential for survival in patients with end-stage renal disease (ESRD); however, HD can also be life-threatening in the final stages of ESRD. Currently, no clear indicators and/or biomarkers exist regarding when HD should be forgone. In the present study, we examined temporal changes in multiple clinical parameters, including biochemical data, physical data, the use of specific medical treatments, nursing care levels, and the activities of daily living (ADL) in 47 ESRD patients who underwent maintenance HD and who died in our hospital. We also investigated the status of informed consents regarding the forgoing of HD in these patients. We found that while biochemical parameters were unaltered, physical parameters such as consciousness levels and blood pressure gradually deteriorated during hospitalization. The use of the following specific medical treatments significantly increased over time: vasopressor use, O inhalation, and ventilator use. The need for 2 nursing care increased and the ADL levels decreased toward the time of death. Medical doctors gave information regarding forgoing HD to patients and/or their family/relatives in 55% of cases, obtained agreement to forego HD in 45% of cases, and HD was actually foregone in 38% of cases. Most clinical parameters were not significantly different between the patients whose HD sessions were forgone versus those in whom HD was continued, indicating that HD was foregone in the very last stages of life. The results suggest that physical parameters, the use of specific medical treatments, the levels of nursing care, and ADL are potential indicators for forgoing HD in the final stages of ESRD.
AB - Maintenance hemodialysis (HD) therapy is essential for survival in patients with end-stage renal disease (ESRD); however, HD can also be life-threatening in the final stages of ESRD. Currently, no clear indicators and/or biomarkers exist regarding when HD should be forgone. In the present study, we examined temporal changes in multiple clinical parameters, including biochemical data, physical data, the use of specific medical treatments, nursing care levels, and the activities of daily living (ADL) in 47 ESRD patients who underwent maintenance HD and who died in our hospital. We also investigated the status of informed consents regarding the forgoing of HD in these patients. We found that while biochemical parameters were unaltered, physical parameters such as consciousness levels and blood pressure gradually deteriorated during hospitalization. The use of the following specific medical treatments significantly increased over time: vasopressor use, O inhalation, and ventilator use. The need for 2 nursing care increased and the ADL levels decreased toward the time of death. Medical doctors gave information regarding forgoing HD to patients and/or their family/relatives in 55% of cases, obtained agreement to forego HD in 45% of cases, and HD was actually foregone in 38% of cases. Most clinical parameters were not significantly different between the patients whose HD sessions were forgone versus those in whom HD was continued, indicating that HD was foregone in the very last stages of life. The results suggest that physical parameters, the use of specific medical treatments, the levels of nursing care, and ADL are potential indicators for forgoing HD in the final stages of ESRD.
KW - Forgoing
KW - Hemodialysis
KW - Withdrawal
UR - http://www.scopus.com/inward/record.url?scp=85082542687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082542687&partnerID=8YFLogxK
U2 - 10.2302/kjm.2019-0001-OA
DO - 10.2302/kjm.2019-0001-OA
M3 - Article
C2 - 31068501
AN - SCOPUS:85082542687
SN - 0022-9717
VL - 69
SP - 16
EP - 25
JO - Keio Journal of Medicine
JF - Keio Journal of Medicine
IS - 1
ER -